Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Kura Oncology (KURA) Operating Expenses: 2010-2024

Historic Operating Expenses for Kura Oncology (KURA) over the last 14 years, with Dec 2024 value amounting to $247.1 million.

  • Kura Oncology's Operating Expenses rose 68.24% to $100.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $343.8 million, marking a year-over-year change of. This contributed to the annual value of $247.1 million for FY2024, which is 49.02% up from last year.
  • Kura Oncology's Operating Expenses amounted to $247.1 million in FY2024, which was up 49.02% from $165.8 million recorded in FY2023.
  • In the past 5 years, Kura Oncology's Operating Expenses ranged from a high of $247.1 million in FY2024 and a low of $91.9 million during FY2020.
  • Its 3-year average for Operating Expenses is $184.2 million, with a median of $165.8 million in 2023.
  • Data for Kura Oncology's Operating Expenses shows a peak YoY spiked of 49.02% (in 2024) over the last 5 years.
  • Kura Oncology's Operating Expenses (Yearly) stood at $91.9 million in 2020, then spiked by 42.83% to $131.3 million in 2021, then grew by 6.56% to $139.9 million in 2022, then grew by 18.55% to $165.8 million in 2023, then soared by 49.02% to $247.1 million in 2024.